Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes

Jimin Guo(North China University of Science and Technology), Jean‐Jacques Lebrun(McGill University Health Centre)
Breast Cancer Research
December 12, 2014
Cited by 29


Related Papers